Skip to main content
SpringerLink
Log in

Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims: Mildly elevated homocysteine (Hcy) and oxidative stress are novel and potentially modifiable risk factors for post-menopausal osteoporosis. We hypothesized that imbalance of oxidant/antioxidant status and increased Hcy concentration stimulates osteoporotic activity, leading to increased collagen I breakdown in post-menopausal women. Methods: Patients were divided into 2 groups (NOP and OP). Group NOP had normal bone mineral density (BMD) and group OP low BMD. Thirty-four (69%) were in group OP and 15 (31%) in group NOP. Serum Total Antioxidant Status (TAS) and Total Peroxide (TPx) levels were determined with new automated methods. The study included measurement of Deoxypyridinoline (DPD). Results: In OP patients plasma t-Hcy, urine deoxypyridinoline and plasma TPx were significantly higher than those in NOP controls. In addition, OP patients also had lower TAS levels than controls, which represent the oxidative imbalance. Pearson’s correlation analysis revealed a negative correlation between t-Hcy and TAS (p<0.038). A significant negative correlation was also found between TAS level and BMD values for the spine in OP patients (p<0.035). In contrast, a positive correlation between t-Hcy and TPx in OP patients was demonstrated significantly, r=0.52, p<0.029. Conclusions: We show that the OP group had reduced TAS, whereas the elevated TPx was different from that in the NOP group. Slightly elevated homocysteinemia may contribute to increasing TPx and reducing TAS in the OP group. However, our results suggest a weak but negative relationship between TAS and BMD. Further investigations are needed to examine the relationship of oxidative stress as an endogenous bioactive agent to bone loss in post-menopausal women. Since oxidative stress is the imbalance between total oxidants and antioxidants in the body, any single oxidant/antioxidant parameter may not reflect overall oxidative stress. Further studies are needed to understand the underlying mechanisms of these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007; 177: 575–80.

    Article  PubMed  Google Scholar 

  2. Herrmann M, Widmann T, Herrmann W. Homocysteine- a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 2005; 43: 1111–7.

    PubMed  CAS  Google Scholar 

  3. Yilmaz N, Kepkep N, Cicek HK et al. Relation of parity and homocysteine to bone mineral density of postmenopausal women. Clin Lab 2006; 52: 49–54.

    PubMed  CAS  Google Scholar 

  4. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clin Chem Lab Med 2005; 43: 1118–23.

    PubMed  CAS  Google Scholar 

  5. Lean JM, Davies JT, Fuller K et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112: 915–23.

    PubMed  CAS  Google Scholar 

  6. Altindag O, Erel O, Soran N, Celik H, Selek S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 2008; 28: 317–21.

    Article  PubMed  CAS  Google Scholar 

  7. Koh JM, Lee YS, Kim YS et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006; 21: 1003–11.

    Article  PubMed  CAS  Google Scholar 

  8. Muthusami S, Ramachandran I, Muthusamy B, Vasudevan G, Prabhu V, Subramaniam. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 2005; 360: 81–6.

    Article  PubMed  CAS  Google Scholar 

  9. Yilmaz N, Bayram M, Erbagci AB, Kilincer MS. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Clin Chem Lab Med 1999; 37: 137–43.

    PubMed  CAS  Google Scholar 

  10. Atmaca A, Gedlik O. Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis. Adv Ther 2006; 23: 842–53.

    Article  PubMed  CAS  Google Scholar 

  11. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112–9.

    Article  PubMed  CAS  Google Scholar 

  12. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103–11.

    Article  PubMed  CAS  Google Scholar 

  13. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005; 51: 2348–53.

    Article  PubMed  CAS  Google Scholar 

  14. Kim DJ, Koh JM, Lee O. Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 2006; 39: 582–90.

    Article  PubMed  CAS  Google Scholar 

  15. Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130: 365S–8.

    PubMed  CAS  Google Scholar 

  16. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 2005; 146: 728–35.

    Article  PubMed  CAS  Google Scholar 

  17. Abdelfatah A, Ducloux D, Toubin G, Motte G, Alber D, Chalopin JM. Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients. Transplantation 2002; 73: 663–5.

    Article  PubMed  CAS  Google Scholar 

  18. Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 2007; 23: 242–7.

    Article  PubMed  Google Scholar 

  19. Hill CH, Mecham R, Starcher B. Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick model. J Nutr 2002; 132: 2143–50.

    PubMed  CAS  Google Scholar 

  20. Majors AK, Pyeritz RE. A deficiency of cysteine impairs fibrillin-1 deposition: implications for the pathogenesis of cystathionine β-synthase deficiency. Mol Genet Metab 2000; 70: 252–60.

    Article  PubMed  CAS  Google Scholar 

  21. Kim HJ, Chang EJ, Kim HM et al. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 2006; 40: 1483–93.

    Article  PubMed  CAS  Google Scholar 

  22. Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006; 79: 160–8.

    Article  PubMed  CAS  Google Scholar 

  23. McLean RR, Jacques PF, Selhub J et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350: 2042–9.

    Article  PubMed  CAS  Google Scholar 

  24. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350: 2033–41.

    Article  PubMed  Google Scholar 

  25. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005; 20: 921–9.

    Article  PubMed  CAS  Google Scholar 

  26. Tucker KL, Hannan MT, Qiao N et al. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res 2005; 20: 152–8.

    Article  PubMed  CAS  Google Scholar 

  27. Dhonukshe-Rutten RA, van Dusseldorp M, Schneede J, de Groot LC, van Staveren WA. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur J Nutr 2005; 44: 341–6.

    Article  PubMed  CAS  Google Scholar 

  28. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504–8.

    Article  PubMed  CAS  Google Scholar 

  29. Maggio D, Barabani M, Pierandrei M. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study, J Clin Endocrinol Metab 2003; 88: 1523–7.

    Article  PubMed  CAS  Google Scholar 

  30. Oh B, Kim SY, Kim DJ et al. Associations of catalase gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women. J Med Genet 2007; 44: 62.

    Article  Google Scholar 

  31. Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R. Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol 2001; 15: 298–303.

    PubMed  CAS  Google Scholar 

  32. Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 2007; 38: 196–205.

    Article  PubMed  CAS  Google Scholar 

  33. Rao LG, Mackinnon ES, Josse RG, Murray TM, Strauss A, Rao AV. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int. 2007; 18: 109–15.

    Article  PubMed  CAS  Google Scholar 

  34. Pasco JA, Henry MJ, Wilkinson LK, Nicholson GC, Schneider HG, Kotowicz MA. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J Womens Health (Larchmt) 2006; 15: 295–300.

    Article  Google Scholar 

  35. Sheweita SA, Khoshhal KI. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 2007; 8: 519–25.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Education and Research Hospital of Antalya and Gaziantep University Medical School, Gaziantep, Turkey

    Necat Yılmaz

  2. Center of Public Health and Women’s Health Laboratory, Antalya, Turkey

    Esin Eren

Authors
  1. Necat Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esin Eren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Necat Yılmaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yılmaz, N., Eren, E. Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin Exp Res 21, 353–357 (2009). https://doi.org/10.1007/BF03324927

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324927

Keywords

Search

Navigation